<DOC>
	<DOC>NCT00752687</DOC>
	<brief_summary>To evaluate the safety, tolerability and pharmacokinetics of ABT-072 in healthy volunteers and its anti-viral activity in HCV infected subjects.</brief_summary>
	<brief_title>A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults</brief_title>
	<detailed_description>A blinded, randomized, placebo-controlled trial to study the safety, tolerability, antiviral activity and pharmacokinetic profiles of ABT-072 in healthy and HCV genotype-1 infected adults.</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Criteria for Healthy Adults: Informed consent has been obtained Subject is in general good health If female, then postmenopausal If female, then not pregnant If male, must be surgically sterile or both he and the partner must use birth control Body Mass Index is 18 to 29, inclusive Criteria for HCVinfected Adults: Infected with HCV for at least 6 months as shown by either detectable HCV RNA or reactive antibody, or liver biopsy with pathology indicative of HCV infection, or disclosure of a risk factor Subject is infected with HCV genotype 1 with detectable HCV RNA of &gt; 50,000 IU/mL Criteria for Healthy Adults: If female, then pregnant or breast feeding Positive HAVIgM, HBsAg, HCV Ab or HIV Ab Within 6 months of start of study, drug or alcohol abuse and use of nicotine products Alcohol intake within 48 hours prior to study drug administration Criteria for HCVinfected Adults: Need for prescription or overthecounter medication Child Pugh score &gt; 5 or clinical evidence of cirrhosis No other cause for liver disease other than HCV infection ALT or AST &gt; 4 x ULN Creatinine &gt; ULN Clinically significant abnormal ECG HCV RNA levels above the level of assay quantification TSH values outside normal range</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Phase 1</keyword>
</DOC>